Voice AI startup Assort Health has raised a $76 million series B round, bringing its total funding to $102 million in just the last four months.
The company automates healthcare call centers with specialty-specific voice AI agents ranging from orthopedics to cardiology to immunology. The AI agents can triage incoming patient calls by answering frequently asked questions and routing patients to the right individual in the clinic.
The series B was led by Lightspeed Venture Partners with participation from Felicis, First Round Capital, Chemistry, A*, Liquid2 and Quiet Capital. The startup's series A in April was co-led by First Round Capital and Chemistry.
The company will use the funds to grow its team and expand its voice AI platform, AssortOS. Assort embeds into the provider’s electronic health record and practice management software to schedule appointments and quickly resolve issues for patients.
It can also accommodate providers’ changing schedule preferences and reduces the amount of time patients have to spend on the phone.
The company touts that customers will see return on investment in roughly 30 days, Jon Wang, co-CEO and co-founder, said in an email.
“Most ‘voice AI’ is a prompt thrown into a voice pipeline,” Jeffery Liu, founder and co-CEO, told Fierce Healthcare. “It’s slow to implement, shallow in coverage and prone to unsafe hallucinations. Assort Intelligence delivers end-to-end automation across scheduling, triage and patient comms with industry leading workflow coverage, patient safety and performance guardrails.”
As part of the funding deal, Assort Health will add Galym Imanbayev, M.D., partner at Lightspeed Venture Partners, to the board, and Paul Ricci, founding CEO of Nuance, will join as a board advisor.
Though the company raised its series A earlier in the year, Wang clarified that the company quickly followed up with its series B round because of demand for the solution.
“We didn’t raise to cover burn; we raised to scale a platform solving an important patient access problem others haven’t been able to solve,” Wang said. “The decision to raise a series B was driven by extraordinary demand from both patients and providers, not financial need.”
Assort Health can also automate other parts of the healthcare workflow such as care navigation, lab tests, prescription renewals and physician referrals.
"Patient engagement is the vital heartbeat of healthcare organizations both clinically and administratively,” Lightspeed Venture Partners' Imanbayev said. “We are thrilled to back Assort Health as it leads the re-platforming of patient engagement into the AI-native era with superior experience for patients and unprecedented outcomes for the organizations that care for them.”